1.42
price up icon0.71%   0.01
after-market After Hours: 1.42
loading
Cocrystal Pharma Inc stock is traded at $1.42, with a volume of 25,355. It is up +0.71% in the last 24 hours and down -19.32% over the past month. Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
See More
Previous Close:
$1.41
Open:
$1.4899
24h Volume:
25,355
Relative Volume:
0.69
Market Cap:
$14.45M
Revenue:
-
Net Income/Loss:
$-17.93M
P/E Ratio:
-0.8023
EPS:
-1.77
Net Cash Flow:
$-14.28M
1W Performance:
-4.05%
1M Performance:
-19.32%
6M Performance:
-22.19%
1Y Performance:
-3.40%
1-Day Range:
Value
$1.3663
$1.4899
1-Week Range:
Value
$1.35
$1.4899
52-Week Range:
Value
$1.35
$3.26

Cocrystal Pharma Inc Stock (COCP) Company Profile

Name
Name
Cocrystal Pharma Inc
Name
Phone
(786) 459-1831
Name
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Name
Employee
12
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
COCP's Discussions on Twitter

Compare COCP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
COCP
Cocrystal Pharma Inc
1.42 14.45M 0 -17.93M -14.28M -1.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-08-20 Initiated H.C. Wainwright Buy

Cocrystal Pharma Inc Stock (COCP) Latest News

pulisher
Apr 03, 2025

COCP stock touches 52-week low at $1.35 amid market fluctuations By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

COCP stock touches 52-week low at $1.35 amid market fluctuations - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

What is Zacks Small Cap’s Estimate for COCP Q3 Earnings? - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

COCP: Norovirus Challenge Study Planned for 2025… - MSN

Apr 01, 2025
pulisher
Mar 31, 2025

Cocrystal Pharma, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Cocrystal Pharma Pushes Forward with Antiviral Programs Despite $17.5M Loss - Stock Titan

Mar 31, 2025
pulisher
Mar 24, 2025

Cocrystal Pharma Inc expected to post a loss of 53 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 20, 2025

Hepatitis C Virus Infection Pipeline 2025: FDA Updates, Therapy - openPR

Mar 20, 2025
pulisher
Mar 20, 2025

Cocrystal Pharma (COCP) to Release Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 14, 2025

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing - The Manila Times

Mar 14, 2025
pulisher
Mar 12, 2025

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines - Investing News Network

Mar 12, 2025
pulisher
Mar 12, 2025

Life Sciences Investor Forum Agenda Announced for March 13th - Morningstar

Mar 12, 2025
pulisher
Mar 07, 2025

Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga

Mar 07, 2025
pulisher
Mar 06, 2025

Cocrystal Pharma to Participate in a Fireside Chat at the - GlobeNewswire

Mar 06, 2025
pulisher
Mar 06, 2025

Kaltura to Host 2025 Investor Event - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Direct Access to Cocrystal Pharma Management: Key Details of Upcoming Zacks Analyst Forum - StockTitan

Mar 06, 2025
pulisher
Mar 04, 2025

Aptorum Gr Stock Price, Quotes and Forecasts | NASDAQ:APM - Benzinga

Mar 04, 2025
pulisher
Mar 03, 2025

Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap - ACCESS Newswire

Mar 03, 2025
pulisher
Feb 27, 2025

New Information Reveals Opportunity in Volatility -- Featured Research on Norsk Hydro, Paragon Offshore, Pure Biosciences and Cocrystal Pharma - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 21, 2025

Global Influenza Vaccine Market is Projected to Cross USD 14 Billion Mark by 2032 | DelveInsight - The Malaysian Reserve

Feb 21, 2025
pulisher
Feb 11, 2025

Cocrystal Pharma And 2 Other Promising US Penny Stocks To Watch - Simply Wall St

Feb 11, 2025
pulisher
Feb 10, 2025

Honeywell International Inc’s (HON) Stock: A Long-Term Performance Analysis - The News Heater

Feb 10, 2025
pulisher
Feb 10, 2025

An In-Depth Look at BP plc ADR’s (BP) Stock Performance - The News Heater

Feb 10, 2025
pulisher
Feb 07, 2025

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development - The Manila Times

Feb 07, 2025
pulisher
Feb 07, 2025

Conduit's AI-Powered Drug Development Takes Major Leap: Real-Time Trial Dashboard Unveiled - StockTitan

Feb 07, 2025
pulisher
Feb 03, 2025

Drugmakers prep for bird flu outbreak, despite continued low risk - PharmaVoice

Feb 03, 2025
pulisher
Jan 30, 2025

Cocrystal Pharma Extends Phase 2a Influenza Drug Study Amid Lower Infection Rates, Stock Near 52-Week High - HPBL

Jan 30, 2025
pulisher
Jan 28, 2025

Influenza Clinical and Non-Clinical Studies, Key Companies, - openPR

Jan 28, 2025
pulisher
Jan 25, 2025

What is Northland Capmk’s Forecast for CECO FY2024 Earnings? - Defense World

Jan 25, 2025
pulisher
Jan 25, 2025

HC Wainwright Forecasts Higher Earnings for Cocrystal Pharma - Defense World

Jan 25, 2025
pulisher
Jan 22, 2025

EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo - Research Tree

Jan 22, 2025
pulisher
Jan 20, 2025

Influenza Pipeline Insights, Clinical Trials Analysis, Emerging Therapies and Companies | DelveInsight - EIN News

Jan 20, 2025
pulisher
Jan 20, 2025

**Cocrystal Pharma, Inc. Presents Corporate Update to Investment Community** - Defense World

Jan 20, 2025
pulisher
Jan 15, 2025

Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL

Jan 15, 2025
pulisher
Jan 13, 2025

Cocrystal Pharma Engages Investors with Limited Disclosure - TipRanks

Jan 13, 2025
pulisher
Jan 11, 2025

Cocrystal Pharma Reports Positive Phase 1 Results with Oral Pan-Viral Protease Inhibitor CDI-988 for Norovirus and Coronavirus Infections - Defense World

Jan 11, 2025
pulisher
Jan 10, 2025

Arcturus Therapeutics launches Phase I Avian Influenza trials in US - Yahoo Finance

Jan 10, 2025
pulisher
Jan 08, 2025

COCP: Phase 2a Trial of CC-42344 Extended - Smartkarma

Jan 08, 2025
pulisher
Jan 08, 2025

COCP: Phase 2a Trial of CC-42344 Extended… - Zacks Small Cap Research

Jan 08, 2025
pulisher
Jan 08, 2025

Cocrystal Pharma Reports Positive Phase 1 Study Results - TipRanks

Jan 08, 2025
pulisher
Jan 08, 2025

Cocrystal Pharma Reports Phase 1 Results with Oral, - GlobeNewswire

Jan 08, 2025
pulisher
Jan 08, 2025

Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections - Yahoo Finance

Jan 08, 2025
pulisher
Jan 02, 2025

Cocrystal to extend enrolment in Phase IIa influenza inhibitor trial - Yahoo Finance

Jan 02, 2025
pulisher
Jan 02, 2025

CLS Holdings USA, Inc. Executes Agreement to Amend Convertible Debentures - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Sees Large Growth in Short Interest - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

BRC Inc. (NYSE: BRCC) Amends Credit Agreements and Enters into $40 Million Term Loan Facility - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

A SPAC III Acquisition Corp Announces Agreement with HD Education Group Limited - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

Supermarket Income REIT (OTCMKTS:SUPIF) Shares Up 0.7% – Should You Buy? - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

Cornish Metals (LON:CUSN) Shares Up 1.1% – What’s Next? - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

Greenwave Technology Solutions (NASDAQ:GWAV) Stock Price Down 3.9% – Here’s What Happened - Defense World

Jan 02, 2025

Cocrystal Pharma Inc Stock (COCP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Cap:     |  Volume (24h):